IMMUNYX
Updated 260 days ago
210 W. 90th Street New York NY 10024
Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Our team of world experts in neutrophil biology and nanoparticle development are using cutting edge tools to bring new therapies to patients across a broad spectrum of diseases. The company was founded based on technology from the Hebrew University with the backing of VLX Ventures.